| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 10/15/2003 | CN1124345C Core sequence of sex-determining genes for milk cow and its application |
| 10/15/2003 | CN1124342C Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
| 10/15/2003 | CN1124341C Monoclonal antibody of p-methyl benzedrine with specificity, hybridoma producing same and kit containing monoclonal antibody and its use |
| 10/14/2003 | US6633818 Method for simultaneous identification of differentially expressed mRNAs and measurement of relative concentrations |
| 10/14/2003 | US6632938 Processes of purifying oligonucleotides |
| 10/14/2003 | US6632937 Nucleic acids and proteins from Cenarchaeum symbiosum |
| 10/14/2003 | US6632933 Use of azetidinone compounds |
| 10/14/2003 | US6632923 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 10/14/2003 | US6632798 Methods for inhibiting angiogenesis |
| 10/14/2003 | US6632681 Reagent delivery device and method of use |
| 10/14/2003 | US6632661 Apparatus for the propagation of microorganisms |
| 10/14/2003 | US6632655 Arrays of flowable or fixed sets disposed within a cavity; useful in assays, as chemical synthesis machines, as nucleic acid or polypeptide sequencing devices, affinity purification devices, calibration and marker devices, molecular capture |
| 10/14/2003 | US6632645 Of given amino acid sequence; use in sequencing, reverse transcription, and amplification reactions |
| 10/14/2003 | US6632644 Nucleotide sequences which code for the zwa1 gene |
| 10/14/2003 | US6632642 Isolated nucleic acid of given sequence; amplification; involved in beer-spoilage |
| 10/14/2003 | US6632641 Filling wells in solid supports with reactants; releasing polynucleotides into solution in wells; amplification |
| 10/14/2003 | US6632632 Rapid method of detection and enumeration of sulfide-producing bacteria in food products |
| 10/14/2003 | US6632631 Identification of antibiotics, preferably antifungals that affect the biosynthesis of lysine |
| 10/14/2003 | US6632630 Quantitative analysis |
| 10/14/2003 | US6632629 Enzyme assay for labeling, separation, detection, and determining the concentration of amino acids, peptides, and proteins in biological samples |
| 10/14/2003 | US6632628 Use to detect compounds having therapeutic activity toward cardiac hypertrophy |
| 10/14/2003 | US6632625 Ob (obesity gene); receptors may be used in various assays, such as a transactivation assay to identify novel ligands |
| 10/14/2003 | US6632618 Morphogenic protein-specific cell surface receptors and uses therefor |
| 10/14/2003 | US6632614 Method for detecting anti-Streptococcus pyogenes DNase B antibody in a test sample |
| 10/14/2003 | US6632613 Compositions and kits for fluorescence polarization assay of large molecules |
| 10/14/2003 | US6632612 Synthesis of chemical tags |
| 10/14/2003 | US6632611 Method of target enrichment and amplification |
| 10/14/2003 | US6632610 Single-stranded trap using a single-strand binding protein |
| 10/14/2003 | US6632609 Amplification of preferential nucleotide sequences; obtain nucleotide sequences, incubate with primers, amplify, recover replication products |
| 10/14/2003 | US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity |
| 10/14/2003 | US6632607 Mycobacterium antibiotic resistance detection |
| 10/14/2003 | US6632606 Methods for single nucleotide polymorphism detection |
| 10/14/2003 | US6632605 Hybridization assays on oligonucleotide arrays |
| 10/14/2003 | US6632600 Altered thermostability of enzymes |
| 10/14/2003 | US6632526 A population of polymeric microspheres dyed with two or more fluorescent squarylium dyes; multiplexed analysis of a plurality of analytes in a single sample |
| 10/14/2003 | US6632460 Treating angina pectoris, reducing the usage of nitroglycerin |
| 10/14/2003 | US6632434 Leptospiral major outer membrane protein, LipL 32 |
| 10/14/2003 | US6632432 Plasma from donors immunized with Staphylococcal epidermidis vaccine comprising antigens in TCA (trichloroacetic acid) extractions |
| 10/14/2003 | US6632430 Administering enzyme inhibitors of S-adenosyl methionine synthetase (SAMS), of S-adenosyl homocysteine hydrolase (SAHH) and of transmethylases, RNA transmethylase and DNA transmethylase; antidotes; detoxification |
| 10/14/2003 | US6632429 Methods for treating pervasive development disorders |
| 10/14/2003 | US6632349 Device comprising electrochemical cell having sensing chamber, electrodes, aperture for admitting sample into chamber, red blood cell lysing agent, and reagent within chamber capable of being reduced by hemoglobin to generate electrical signal |
| 10/14/2003 | US6632339 Electroblotting separated polypeptides from electrophoresis gel through hydrophilic membrane with immobilized cleaving reagent so polypeptides are cleaved into fragments, collecting on hydrophobic member, identifying fragments |
| 10/14/2003 | US6632271 MBI bioaerosol vortex cassette |
| 10/14/2003 | CA2288376C Syndecan interacting proteins and the use thereof |
| 10/14/2003 | CA2215167C Reagent stabilized using coenzyme reduction system |
| 10/14/2003 | CA2167521C Compositions and methods for producing sialyltransferases |
| 10/14/2003 | CA2081657C Denatured vehicular proteins to improve enzyme linked immunosorbent assays |
| 10/14/2003 | CA2066561C Methods for rapid microbial detection |
| 10/12/2003 | CA2425021A1 Control of the ratio of lap to lip |
| 10/09/2003 | WO2003083757A2 Methods and computer program products for the quality control of nucleic acid assays |
| 10/09/2003 | WO2003083660A1 Adaptive behavioral intrusion detection systems and methods |
| 10/09/2003 | WO2003083490A2 Method for predicting antiphospholid syndrome |
| 10/09/2003 | WO2003083489A1 System for performing blood coagulation assays and measuring blood clotting times |
| 10/09/2003 | WO2003083485A2 Protein for use in hypoxia related conditions |
| 10/09/2003 | WO2003083482A1 Camp-regulated phosphoprotein for diagnostic and therapeutic use in neurodegenerative diseases |
| 10/09/2003 | WO2003083481A2 Luminescent, spheroid, non-autofluorescent silica gel particles having variable emission intensities and frequencies |
| 10/09/2003 | WO2003083476A1 Detection of dna-binding proteins |
| 10/09/2003 | WO2003083473A1 Substrates for hybridization and method of using the same |
| 10/09/2003 | WO2003083443A2 Lipid mediated screening of drug candidates for identification of active compounds |
| 10/09/2003 | WO2003083442A2 Life sciences business systems and methods |
| 10/09/2003 | WO2003083440A2 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 10/09/2003 | WO2003083435A2 Single primer isothermal nucleic acid amplification-enhanced analyte detection and quantification |
| 10/09/2003 | WO2003083142A2 UNIVERSAL DETECTION OF HUMAN PAPILLOMAVIRUS mRNA |
| 10/09/2003 | WO2003083141A1 Interpreting cytological specimens via molecular histological signatures |
| 10/09/2003 | WO2003083140A2 Classification and prognosis prediction of acute lymphoblasstic leukemia by gene expression profiling |
| 10/09/2003 | WO2003083139A1 Method of examining allergic disease |
| 10/09/2003 | WO2003083138A2 Methods of evaluating dna-based links |
| 10/09/2003 | WO2003083137A2 Detection of circularized immobilized nucleic acid probes |
| 10/09/2003 | WO2003083136A1 Method and kit for detecting membrane protein-protein interactions |
| 10/09/2003 | WO2003083135A2 Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) |
| 10/09/2003 | WO2003083134A1 Sensor for the quantitative and qualitative determination of (bio)organic oligomers and polymers, corresponding analysis method, and method for the production of said sensor |
| 10/09/2003 | WO2003083133A1 Method of detecting mild impaired glucose tolerance or insulin hyposecretion |
| 10/09/2003 | WO2003083132A1 Visulization of introduced dna (void) in transit by in situ hybridization |
| 10/09/2003 | WO2003083131A1 Method for the identification of microorganisms by means of in situ hybridization and flow cytometry |
| 10/09/2003 | WO2003083130A2 Detection of malaria parasites by mass spectrometry |
| 10/09/2003 | WO2003083129A2 Universal signal amplification tail |
| 10/09/2003 | WO2003083127A2 Method and system for determining absolute mrna quantities |
| 10/09/2003 | WO2003083115A1 Abc transporter-associated gene abcc13 |
| 10/09/2003 | WO2003083113A2 Growth regulating proteins |
| 10/09/2003 | WO2003083112A1 Cell population provided with identification codes and method of screening cell population |
| 10/09/2003 | WO2003083110A1 Novel galactose transferases, peptides thereof and nucleic acid encoding the same |
| 10/09/2003 | WO2003083108A1 Gene examination method for judging the onset risk of glaucoma |
| 10/09/2003 | WO2003083107A1 Cpg retrieval of dna from formalin-fixed pathology specimen for promoter methylation analysis |
| 10/09/2003 | WO2003083106A1 Method of assaying target nucleic acid and kit therefor |
| 10/09/2003 | WO2003083101A1 Dap kinase crystals, method of screening candidate for drug targeting dap kinase using the same and drug obtained thereby |
| 10/09/2003 | WO2003083098A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |
| 10/09/2003 | WO2003083096A2 Cancer associated protein kinases and their uses |
| 10/09/2003 | WO2003083094A1 Hbv drug resistance drug resistance detection methods |
| 10/09/2003 | WO2003083074A2 Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas |
| 10/09/2003 | WO2003083058A2 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 10/09/2003 | WO2003083056A2 Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 10/09/2003 | WO2003083055A2 Hybridization rate enhancement for substrate-bound specific nucleic acid-binding agents |
| 10/09/2003 | WO2003083053A2 Constructing very long dna sequences from synthetic dna molecules |
| 10/09/2003 | WO2003083051A2 Multiplex standardized reverse transcriptase-polymerase chain reaction method for assessment of gene expression in small biological samples |
| 10/09/2003 | WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 10/09/2003 | WO2003083047A2 MP53s AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 10/09/2003 | WO2003083045A2 Lambda integrase mediated recombination in plants |
| 10/09/2003 | WO2003083044A2 Tissue analogs for in vitro testing and method of use therefor |
| 10/09/2003 | WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 10/09/2003 | WO2003083038A2 Disruption of the redk gene |